John L Knopf Insider Trading $XLRN ACCELERON PHARMA INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John L Knopf.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John L Knopf. John L Knopf is CEO and President in ACCELERON PHARMA INC ($XLRN).
John L Knopf in ACCELERON PHARMA INC
Trading Symbol: XLRNIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John L Knopf: CEO and President
Holdings: 245,627 shares
Current Value: $5,831,185
Latest Transaction: Nov 14 2016
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John L Knopf in ACCELERON PHARMA INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 14 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.08 | 5,606 | 28,478 | 109,027 | |
Nov 14 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.28 | 15,976 | 84,353 | 21,524 | |
Nov 14 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.28 | 9,375 | 49,500 | 28,125 | |
Nov 14 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.28 | 37,500 | 198,000 | 12,500 | |
Nov 14 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.88 | 31,543 | 185,473 | 18,457 | |
Nov 14 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 32.19 | 100,000 | 3,219,000 | 214,084 | 314.1 K to 214.1 K (-31.84 %) |
Nov 14 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.08 | 5,606 | 28,478 | 314,084 | 308.5 K to 314.1 K (+1.82 %) |
Nov 14 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.28 | 15,976 | 84,353 | 308,478 | 292.5 K to 308.5 K (+5.46 %) |
Nov 14 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.28 | 9,375 | 49,500 | 292,502 | 283.1 K to 292.5 K (+3.31 %) |
Nov 14 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.28 | 37,500 | 198,000 | 283,127 | 245.6 K to 283.1 K (+15.27 %) |
Nov 14 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.88 | 31,543 | 185,473 | 245,627 | 214.1 K to 245.6 K (+14.73 %) |
Jul 07 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 1.80 | 95,000 | 171,000 | 0 | |
Jul 07 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 1.80 | 95,000 | 171,000 | 214,084 | 119.1 K to 214.1 K (+79.78 %) |
Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.28 | 41,477 | 218,999 | 42,500 | |
Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.28 | 30,501 | 161,045 | 83,977 | |
Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.28 | 23,022 | 121,556 | 114,478 | |
Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 34.26 | 10,437 | 357,572 | 119,084 | 129.5 K to 119.1 K (-8.06 %) |
Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 33.58 | 31,040 | 1,042,323 | 129,521 | 160.6 K to 129.5 K (-19.33 %) |
Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.28 | 41,477 | 218,999 | 160,561 | 119.1 K to 160.6 K (+34.83 %) |
Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 34.22 | 2,390 | 81,786 | 119,084 | 121.5 K to 119.1 K (-1.97 %) |
Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 33.18 | 28,111 | 932,723 | 121,474 | 149.6 K to 121.5 K (-18.79 %) |
Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.28 | 30,501 | 161,045 | 149,585 | 119.1 K to 149.6 K (+25.61 %) |
Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 34.92 | 20,626 | 720,260 | 119,084 | 139.7 K to 119.1 K (-14.76 %) |
Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 34.18 | 7,396 | 252,795 | 139,710 | 147.1 K to 139.7 K (-5.03 %) |
Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.28 | 23,022 | 121,556 | 147,106 | 124.1 K to 147.1 K (+18.55 %) |
May 20 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.08 | 25,787 | 130,998 | 114,633 | |
May 20 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.08 | 37,623 | 191,125 | 140,420 | |
May 20 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.08 | 24,090 | 122,377 | 178,043 | |
May 20 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 33.17 | 25,787 | 855,355 | 124,084 | 149.9 K to 124.1 K (-17.21 %) |
May 20 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.08 | 25,787 | 130,998 | 149,871 | 124.1 K to 149.9 K (+20.78 %) |
May 20 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 33.04 | 37,623 | 1,243,064 | 124,084 | 161.7 K to 124.1 K (-23.27 %) |
May 20 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.08 | 37,623 | 191,125 | 161,707 | 124.1 K to 161.7 K (+30.32 %) |
May 20 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 33.04 | 36,590 | 1,208,934 | 124,084 | 160.7 K to 124.1 K (-22.77 %) |
May 20 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.08 | 24,090 | 122,377 | 160,674 | 136.6 K to 160.7 K (+17.64 %) |
Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | A | 27.97 | 105,000 | 2,936,850 | 105,000 | |
Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Grant | A | 0.00 | 17,500 | 0 | 136,584 | 119.1 K to 136.6 K (+14.70 %) |
Oct 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.08 | 19,000 | 96,520 | 202,133 | |
Oct 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 24.58 | 12,452 | 306,070 | 119,084 | 131.5 K to 119.1 K (-9.47 %) |
Oct 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 24.01 | 6,548 | 157,217 | 131,536 | 138.1 K to 131.5 K (-4.74 %) |
Oct 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.08 | 19,000 | 96,520 | 138,084 | 119.1 K to 138.1 K (+15.96 %) |
Sep 15 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 0.40 | 8,500 | 3,400 | 0 | |
Sep 15 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 0.40 | 8,500 | 3,400 | 119,084 | 110.6 K to 119.1 K (+7.69 %) |
Sep 11 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Grant | A | 0.00 | 89,000 | 0 | 110,584 | 21.6 K to 110.6 K (+412.34 %) |
Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.08 | 19,000 | 96,520 | 221,133 | |
Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 31.06 | 5,173 | 160,673 | 21,584 | 26.8 K to 21.6 K (-19.33 %) |
Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 30.27 | 9,028 | 273,278 | 26,757 | 35.8 K to 26.8 K (-25.23 %) |
Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 29.16 | 4,799 | 139,939 | 35,785 | 40.6 K to 35.8 K (-11.82 %) |
Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.08 | 19,000 | 96,520 | 40,584 | 21.6 K to 40.6 K (+88.03 %) |
Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.08 | 19,000 | 96,520 | 240,133 | |
Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 29.22 | 500 | 14,610 | 21,584 | 22.1 K to 21.6 K (-2.26 %) |
Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 28.51 | 18,500 | 527,435 | 22,084 | 40.6 K to 22.1 K (-45.58 %) |
Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.08 | 19,000 | 96,520 | 40,584 | 21.6 K to 40.6 K (+88.03 %) |
Aug 03 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 0.40 | 4,000 | 1,600 | 8,500 | |
Aug 03 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 0.40 | 4,000 | 1,600 | 21,584 | 17.6 K to 21.6 K (+22.75 %) |
Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.08 | 3,367 | 17,104 | 259,133 | |
Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 3.88 | 15,633 | 60,656 | 27,867 | |
Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 30.25 | 1,400 | 42,350 | 17,584 | 19 K to 17.6 K (-7.37 %) |
Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 29.66 | 17,600 | 522,016 | 18,984 | 36.6 K to 19 K (-48.11 %) |
Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.08 | 3,367 | 17,104 | 36,584 | 33.2 K to 36.6 K (+10.14 %) |
Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 3.88 | 15,633 | 60,656 | 33,217 | 17.6 K to 33.2 K (+88.90 %) |
Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 3.88 | 19,000 | 73,720 | 43,500 | |
Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 32.94 | 600 | 19,764 | 17,584 | 18.2 K to 17.6 K (-3.30 %) |
Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 32.50 | 18,400 | 598,000 | 18,184 | 36.6 K to 18.2 K (-50.30 %) |
Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 3.88 | 19,000 | 73,720 | 36,584 | 17.6 K to 36.6 K (+108.05 %) |
May 13 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 1.80 | 5,000 | 9,000 | 95,000 | |
May 13 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 3.88 | 20,000 | 77,600 | 62,500 | |
May 13 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 1.80 | 5,000 | 9,000 | 17,584 | 12.6 K to 17.6 K (+39.73 %) |
May 13 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 32.34 | 900 | 29,106 | 12,584 | 13.5 K to 12.6 K (-6.67 %) |
May 13 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 31.77 | 19,100 | 606,807 | 13,484 | 32.6 K to 13.5 K (-58.62 %) |
May 13 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 3.88 | 20,000 | 77,600 | 32,584 | 12.6 K to 32.6 K (+158.93 %) |
Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 3.88 | 5,000 | 19,400 | 82,500 | |
Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 35.45 | 500 | 17,725 | 12,584 | 13.1 K to 12.6 K (-3.82 %) |
Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 34.80 | 4,500 | 156,600 | 13,084 | 17.6 K to 13.1 K (-25.59 %) |
Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 3.88 | 5,000 | 19,400 | 17,584 | 12.6 K to 17.6 K (+39.73 %) |
Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 35.39 | 2,100 | 74,319 | 12,584 | 14.7 K to 12.6 K (-14.30 %) |
Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 34.75 | 7,900 | 274,525 | 14,684 | 22.6 K to 14.7 K (-34.98 %) |
Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 35.43 | 500 | 17,715 | 22,584 | 23.1 K to 22.6 K (-2.17 %) |
Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 34.80 | 4,500 | 156,600 | 23,084 | 27.6 K to 23.1 K (-16.31 %) |
Mar 10 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 40.93 | 2,501 | 102,366 | 27,584 | 30.1 K to 27.6 K (-8.31 %) |
Mar 10 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 40.15 | 17,499 | 702,585 | 30,085 | 47.6 K to 30.1 K (-36.77 %) |
Feb 11 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 37.20 | 1,937 | 72,056 | 47,584 | 49.5 K to 47.6 K (-3.91 %) |
Feb 11 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 36.59 | 18,063 | 660,925 | 49,521 | 67.6 K to 49.5 K (-26.73 %) |
Jan 28 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Gift | G | 0.00 | 1,416 | 0 | 67,584 | 69 K to 67.6 K (-2.05 %) |
Jan 22 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 0.40 | 12,500 | 5,000 | 0 | |
Jan 22 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 0.40 | 12,500 | 5,000 | 69,000 | 56.5 K to 69 K (+22.12 %) |
Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | A | 41.20 | 151,000 | 6,221,200 | 151,000 | |
Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 39.66 | 18,800 | 745,608 | 56,500 | 75.3 K to 56.5 K (-24.97 %) |
Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 38.93 | 1,200 | 46,716 | 75,300 | 76.5 K to 75.3 K (-1.57 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 47.45 | 451 | 21,400 | 76,500 | 77 K to 76.5 K (-0.59 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 46.54 | 1,200 | 55,848 | 76,951 | 78.2 K to 77 K (-1.54 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 45.10 | 4,300 | 193,930 | 78,151 | 82.5 K to 78.2 K (-5.22 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 44.35 | 7,036 | 312,047 | 82,451 | 89.5 K to 82.5 K (-7.86 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 42.90 | 5,413 | 232,218 | 89,487 | 94.9 K to 89.5 K (-5.70 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 41.58 | 400 | 16,632 | 94,900 | 95.3 K to 94.9 K (-0.42 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 40.55 | 800 | 32,440 | 95,300 | 96.1 K to 95.3 K (-0.83 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 38.43 | 400 | 15,372 | 96,100 | 96.5 K to 96.1 K (-0.41 %) |
Nov 14 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 33.57 | 9,399 | 315,524 | 96,500 | 105.9 K to 96.5 K (-8.88 %) |
Nov 14 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 32.57 | 10,601 | 345,275 | 105,899 | 116.5 K to 105.9 K (-9.10 %) |
Oct 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 30.20 | 10,000 | 302,000 | 116,500 | 126.5 K to 116.5 K (-7.91 %) |
Oct 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 29.22 | 10,000 | 292,200 | 126,500 | 136.5 K to 126.5 K (-7.33 %) |
Sep 10 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 24.77 | 220 | 5,449 | 136,500 | 136.7 K to 136.5 K (-0.16 %) |
Sep 10 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 24.21 | 6,447 | 156,082 | 136,720 | 143.2 K to 136.7 K (-4.50 %) |
Sep 10 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 24.71 | 227 | 5,609 | 143,167 | 143.4 K to 143.2 K (-0.16 %) |
Sep 10 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 24.21 | 6,406 | 155,089 | 143,394 | 149.8 K to 143.4 K (-4.28 %) |
Sep 10 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 24.92 | 3,367 | 83,906 | 149,800 | 153.2 K to 149.8 K (-2.20 %) |
Sep 10 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 24.91 | 3,333 | 83,025 | 153,167 | 156.5 K to 153.2 K (-2.13 %) |
Aug 15 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 29.78 | 7,500 | 223,350 | 156,500 | 164 K to 156.5 K (-4.57 %) |
Aug 15 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 29.78 | 10,000 | 297,800 | 164,000 | 174 K to 164 K (-5.75 %) |
Jul 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 32.58 | 2,083 | 67,864 | 174,000 | 176.1 K to 174 K (-1.18 %) |
Jul 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 31.42 | 5,417 | 170,202 | 176,083 | 181.5 K to 176.1 K (-2.98 %) |
Jul 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 32.66 | 2,488 | 81,258 | 181,500 | 184 K to 181.5 K (-1.35 %) |
Jul 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 31.43 | 7,512 | 236,102 | 183,988 | 191.5 K to 184 K (-3.92 %) |
Jun 11 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 31.99 | 2,800 | 89,572 | 191,500 | 194.3 K to 191.5 K (-1.44 %) |
Jun 11 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 31.19 | 2,200 | 68,618 | 194,300 | 196.5 K to 194.3 K (-1.12 %) |
Jun 11 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 31.98 | 6,109 | 195,366 | 196,500 | 202.6 K to 196.5 K (-3.02 %) |
Jun 11 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 31.14 | 3,891 | 121,166 | 202,609 | 206.5 K to 202.6 K (-1.88 %) |
May 21 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 32.20 | 287 | 9,241 | 206,500 | 206.8 K to 206.5 K (-0.14 %) |
May 21 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 31.49 | 9,713 | 305,862 | 206,787 | 216.5 K to 206.8 K (-4.49 %) |
May 21 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 32.23 | 100 | 3,223 | 216,500 | 216.6 K to 216.5 K (-0.05 %) |
May 21 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 31.51 | 4,900 | 154,399 | 216,600 | 221.5 K to 216.6 K (-2.21 %) |
Dec 09 2013 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | A | 24.11 | 110,000 | 2,652,100 | 110,000 |
Page: 1